$CLMT

Mawer Stephen P sold 24,555 shares of CLMT

Mawer Stephen P sold 24,555 shares of Calumet, Inc. /DE (CLMT) on 2026-09-25.

Original reporting
SEC EDGAR · Mawer Stephen P
Published Sep 28, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 2:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CLMT
Bearish
medium confidence
Mentioned
$CLMT
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLMTBearishLow
01

Why it matters

The director's sale is a primary disclosure but modest in scale, offering limited trading insight.

02

Market read

Insider sale provides a small bearish signal for CLMT but is unlikely to move the stock significantly.

03

What to watch

Lack of price information and the director's overall stake reduce materiality.

Relevance 4/10Novelty 5/10Timing: post-filing today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$CLMTBearishMedium confidence
Context

Director Stephen Mawer sold 24,555 shares of Calumet, Inc. in a Form 4 filing.

Expected impact

likely slight downward pressure as market prices in the insider sell

Evidence & confidence

A director's open‑market sale of ~24k shares signals personal liquidity need; no price disclosed, but the size relative to holdings suggests limited impact.

Market effects

Minimal effect on the broader mining sector.

No notable regional impact.

Limited to investors tracking insider activity.

Counterpoint

The sale could be routine and not indicative of future performance.

Key entities

  • Calumet, Inc.

    US‑listed mining company (ticker CLMT).

  • Stephen P. Mawer

    Director of Calumet, Inc. who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CLMTHighAI 8/10

Calumet reports Q2 EPS ($1.09) vs. ($1.70) last year

Calumet Specialty Products Partners (CLMT) reported Q2 EPS of ($1.09), an improvement from ($1.70) last year. Revenue rose to $1.45B from $1.03B. CEO Todd Borgmann highlighted strong margin performance and debt reduction. The company's Montana Renewables unit completed the first phase of a fuel expansion project.

$CLMTMed

Q2 Earnings Highlights: Calumet (NASDAQ:CLMT) Vs The Rest Of The Infrastructure Stocks

Calumet (CLMT) stock rose 8.9% post-earnings, trading at $16.19. Kodiak Gas Services (KGS) reported $391.1M revenue, up 21.1% YoY, with stock up 10.5% to $62.81. Excelerate Energy (EE) saw $329.3M revenue, up 61% YoY, with stock up 3% to $39.65. DHT Holdings (DHT) reported $255.2M revenue, up 174% YoY, with stock up 13% to $20.19. Market focus has shifted from AI to geopolitics and back to fundamentals.

$CLMTMed

Why Calumet Stock Topped the Market Today

Calumet (CLMT) stock rose 3% after the EPA granted full exemptions for two refineries, removing 71 million RINs from its balance sheet. The company values remaining RINs at $309 million. Calumet is also seeking exemptions for 2022-2024, which are under review. The exemptions improve its financials by reducing compliance costs.